Float Short %

4.09

Margin Of Safety %

-9

Put/Call OI Ratio

0.98

EPS Next Q Diff

-0.08

EPS Last/This Y

0.36

EPS This/Next Y

0.49

Price

73.07

Target Price

86.16

Analyst Recom

1.52

Performance Q

21.46

Upside

0.1%

Beta

1.48

Ticker: DXCM

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-01-23	DXCM	72.85	0.88	0.25	114405
2026-01-26	DXCM	73.33	0.90	0.52	108576
2026-01-27	DXCM	73.7	0.89	0.35	110001
2026-01-28	DXCM	73.36	0.88	0.96	110611
2026-01-29	DXCM	74.04	0.89	0.71	111104
2026-01-30	DXCM	73.03	0.89	0.62	111506
2026-02-02	DXCM	72.55	0.92	1.07	108719
2026-02-03	DXCM	71.66	0.92	1.04	109387
2026-02-05	DXCM	69.95	0.94	0.58	109321
2026-02-09	DXCM	70.18	0.96	1.19	106276
2026-02-10	DXCM	68.16	0.95	2.03	106560
2026-02-11	DXCM	68.02	0.96	4.39	108045
2026-02-12	DXCM	65.09	1.00	1.52	111088
2026-02-13	DXCM	70.02	1.02	0.43	116722
2026-02-17	DXCM	70.43	0.98	0.43	110270
2026-02-18	DXCM	72.88	0.98	0.33	110763
2026-02-19	DXCM	72.26	0.98	0.65	110761
2026-02-20	DXCM	73.08	0.98	0.65	110983
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-01-23	DXCM	72.85	43.8	-38.0	2.06
2026-01-26	DXCM	73.38	44.4	-16.8	2.06
2026-01-27	DXCM	73.68	44.4	-19.3	2.06
2026-01-28	DXCM	73.37	44.4	43.9	2.06
2026-01-29	DXCM	74.02	44.4	57.7	2.06
2026-01-30	DXCM	73.08	44.4	35.1	2.06
2026-02-02	DXCM	72.53	44.4	40.8	2.06
2026-02-03	DXCM	71.65	44.4	35.5	2.06
2026-02-04	DXCM	70.84	44.4	36.6	2.06
2026-02-05	DXCM	69.91	44.5	34.6	2.06
2026-02-06	DXCM	70.00	44.5	49.9	2.06
2026-02-09	DXCM	70.17	44.6	51.2	2.06
2026-02-10	DXCM	68.14	45.2	17.8	2.06
2026-02-11	DXCM	68.12	45.2	47.6	2.06
2026-02-12	DXCM	65.09	44.6	0.8	2.06
2026-02-13	DXCM	70.08	44.6	125.8	2.06
2026-02-17	DXCM	70.44	48.1	-74.2	2.50
2026-02-18	DXCM	72.79	48.1	-45.2	2.50
2026-02-19	DXCM	72.26	48.1	-88.3	2.50
2026-02-20	DXCM	73.07	48.1	-	2.50
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-01-23	DXCM	-0.02	2.13	3.75
2026-01-26	DXCM	-0.02	1.21	3.75
2026-01-27	DXCM	-0.02	1.21	3.75
2026-01-28	DXCM	-0.02	1.21	4.02
2026-01-29	DXCM	-0.02	1.21	4.02
2026-01-30	DXCM	0.00	1.21	4.02
2026-02-02	DXCM	0.00	1.14	4.02
2026-02-03	DXCM	0.00	1.14	4.02
2026-02-04	DXCM	0.00	1.14	4.02
2026-02-05	DXCM	0.00	1.14	4.02
2026-02-06	DXCM	0.00	1.14	4.02
2026-02-09	DXCM	0.00	-0.34	4.02
2026-02-10	DXCM	0.00	-0.34	4.02
2026-02-11	DXCM	0.00	-0.34	4.04
2026-02-12	DXCM	0.00	-0.34	4.04
2026-02-13	DXCM	0.00	-0.34	4.04
2026-02-17	DXCM	-0.02	2.00	4.09
2026-02-18	DXCM	-0.02	2.00	4.09
2026-02-19	DXCM	0.04	2.00	4.09
2026-02-20	DXCM	0.04	2.00	4.09
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.68

Avg. EPS Est. Current Quarter

0.47

Avg. EPS Est. Next Quarter

0.6

Insider Transactions

0.04

Institutional Transactions

Beta

1.48

Average Sales Estimate Current Quarter

1175

Average Sales Estimate Next Quarter

1296

Fair Value

66.4

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

55.7

Max Drawdown 5-Year %

-66.3

Target Price

86.16

P/E

34.92

Forward P/E

24.47

PEG

1.25

P/S

6.03

P/B

10.24

P/Free Cash Flow

26.11

EPS

2.09

Average EPS Est. Cur. Y

2.5

EPS Next Y. (Est.)

2.99

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

17.94

Relative Volume

0.62

Return on Equity vs Sector %

1.4

Return on Equity vs Industry %

12.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

DexCom, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 11000

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

stock quote shares DXCM – DexCom, Inc. Stock Price stock today

news today DXCM – DexCom, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch DXCM – DexCom, Inc. yahoo finance google finance

stock history DXCM – DexCom, Inc. invest stock market

stock prices DXCM premarket after hours

ticker DXCM fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: DXCM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y